The romanticism of the city—and the vibrant tradition of artistic imagination at the Biennale—is the perfect backdrop for season’s most daring looks.
NYS Entity Status
NYS Filing Date
APRIL 25, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - MAGIC FASHIONS WORLDWIDE INC.
AROUND THE WEB
- The Magic of Fall Fashion at the Venice Biennale
Monday Aug 14, 2017
- Intel to deploy 100 self-driving vehicles worldwide by end of year
By David Curry - Tuesday Aug 15, 2017
Intel will deploy 100 self-driving vehicles in Europe, Israel, and the United States by the end of the year. The cars will be used as demonstration vehicles for customers and regulators, as well as test vehicles for the company’s self-driving efforts.The announcement comes alongside the completion of its $15.3 billion Mobileye acquisition, which it announced in March this year. Mobileye will supply the sensors and computer vision, while Intel supplies the processing power and expertise in 5G and cloud communication.See Also: Intel “eliminates” wearables division to focus on augmented...Read More
- How to Get to New York During Penn Station’s Summer Repairs
By TOM WRIGHT-PIERSANTI - Thursday Jul 6, 2017
Starting July 10, repairs at Penn Station will disrupt the daily commute for thousands of Long Island Rail Road and New Jersey Transit riders. Here is a guide to help navigate the rails this summer.
- Does Electroconvulsive Therapy Improve Huntington’s Disease?
Wednesday Jul 19, 2017
For over 70 years Electroconvulsive Therapy (ECT) has been used to treat severe depression and there are reports that it could help patients with Huntington’s Disease who experience psychiatric symptoms. Many patients with Huntington’s Disease experience depression, with suicide rates 5 to 10 times higher than the general public. In 21 published case reports where -
- MSH3 Gene Reveals Critical Link With Huntington’s Disease
Wednesday Aug 9, 2017
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.